Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Edwards Lifesciences AG et al v. Corevalve Inc., et al
Case Number:
1:08-cv-00091
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 15, 2014
Medtronic Judge Backs Up Ban As Case Heads To Fed. Circ.
A Delaware federal judge released a written opinion Tuesday explaining that he had on Friday barred most U.S. sales of Medtronic Inc.'s allegedly infringing heart valve systems because rival Edwards Lifesciences AG was likely to win on the merits — a ruling Medtronic has already appealed to the Federal Circuit.
-
April 14, 2014
Medtronic Asks Fed. Circ. To Lift CoreValve Sales Ban
Medtronic Inc. on Monday asked the Federal Circuit to stay a preliminary injunction on U.S. sales of a heart valve system that Edwards Lifesciences AG claims infringes its catheter patent, claiming the ban jeopardizes patient health and misinterprets patent extension law.
-
April 25, 2013
Edwards Says Heart Valve IP Still Infringed After $74M Verdict
Edwards Lifesciences Corp. on Wednesday asked a Delaware federal judge to award it additional damages and a permanent injunction against CoreValve Inc., alleging its rival was still infringing a patent for catheter heart valve technology despite the Federal Circuit recently upholding a $73.9 million verdict against CoreValve.